BeStock  
Stocks › Biotechnology › NTLA

Intellia Therapeutics NTLA

US equityMarket cap rank #2862BiotechnologyGene Editing
$12.75 +$0.49 (+4.00%)
Pre-market · Oct 6, 4:10 am ET · After hours $12.75 0.00%
Open$12.35
Prev close$12.26
Day range$11.85 – $12.88
Volume4.97M
Market cap$1.79B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts12
Average target$20.50+60.8% vs. price
  • Buy 50%
  • Hold 33%
  • Sell 17%
Low $9.00Now $12.75Avg $20.50High $49.00

Recent rating changes

The last 20 actions on file set price targets from $9.00 to $49.00, averaging $22.25.

DateFirmRatingTarget
9 Sep 2026 Wedbush HOLD $13.00
9 Sep 2026 H.C. Wainwright BUY $25.00
4 Sep 2026 TD Cowen BUY –
14 Aug 2026 JonesTrading BUY $29.00
10 Aug 2026 Morgan Stanley HOLD $15.00
7 Aug 2026 BofA Securities HOLD $17.00
7 Aug 2026 Evercore BUY $24.00
7 Aug 2026 H.C. Wainwright BUY $25.00
6 Aug 2026 CCORF BUY $49.00
6 Aug 2026 William Blair BUY –
6 Aug 2026 Evercore BUY $24.00
6 Aug 2026 Goldman Sachs SELL $9.00
6 Aug 2026 RBC Capital HOLD $15.00
15 Jul 2026 Wolfe Research SELL $9.00
16 Jun 2026 CCORF BUY $49.00
15 Jun 2026 William Blair BUY –
15 Jun 2026 BofA Securities HOLD $19.00
15 Jun 2026 H.C. Wainwright BUY $25.00
14 Jun 2026 TD Cowen BUY –
14 Jun 2026 Goldman Sachs SELL $9.00

Discussion

No comments yet — be the first to weigh in on NTLA.

Leave a comment

Scroll to Top